Drugs / [18F]FLOR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04528199 | Feb 2021 → Apr 2023 | metastatic prostate carcinoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]FLOR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04528199 ↗ |
| Known as | FC303 | “[18F]FLOR (FC303) Injection” NCT04528199 ↗ |
| Modality | Diagnostic / imaging agent | “diagnostic performance of \[18F\]FLOR (FC303) PET/CT imaging” NCT04528199 ↗ |